Pulmonary arterial hypertension associated with chronic hemolytic anemia

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Pulmonary arterial hypertension associated with chronic hemolytic anemia.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Pulmonary arterial hypertension associated with chronic hemolytic anemia.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Zemplar

(paricalcitol)Orphan drugstandard

Abbvie, inc.

Vitamin D2 Analog [EPC]

12.1 Mechanism of Action Paricalcitol is a synthetic, biologically active vitamin D 2 analog of calcitriol. Preclinical and in vitro studies have demo...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Pulmonary arterial hypertension associated with chronic hemolytic anemia.
Search all trials →
Search clinical trials for Pulmonary arterial hypertension associated with chronic hemolytic anemia

Recent News & Research

No recent news articles indexed yet for Pulmonary arterial hypertension associated with chronic hemolytic anemia.
Search PubMed for Pulmonary arterial hypertension associated with chronic hemolytic anemia

Browse all Pulmonary arterial hypertension associated with chronic hemolytic anemia news →

Specialist Network

No specialists currently listed for Pulmonary arterial hypertension associated with chronic hemolytic anemia.

View all Pulmonary arterial hypertension associated with chronic hemolytic anemia specialists →

Quick Actions